The selection and use of essential medicines : report of the WHO Expert Committee, 2002.

Format:

Book

Conference/Event

Author/Creator:

WHO Expert Committee on the Selection and Use of Essential Medicines. Meeting (12th : 2002 : Geneva, Switzerland)

Contributor:

World Health Organization.

Conference Name:

WHO Expert Committee on the Selection and Use of Essential Medicines. (12th : 2002 : Geneva, Switzerland)

Series:

Technical report series (World Health Organization) ; 914.

WHO technical report series ; 914

Language:

English

Subjects (All):

Drugs--Standards--Congresses.

Drugs.

Medicine--Formulae, receipts, prescriptions--Congresses.

Medicine.

Drug utilization--Standards--Congresses.

Drug utilization.

Physical Description:

132 p.

Edition:

1st ed.

Place of Publication:

Geneva : World Health Organization, 2003.

Language Note:

English

Summary:

This report presents the recommendations of the WHO Expert Committee responsible for updating the WHO Model List of Essential Medicines. The first part contains an update on the revised procedures for updating the Model List and the development of the WHO Essential Medicines Library. It continues to present a summary of the Committee's considerations and justifications for additions and changes to the 12th Model List, including its recommendation to add ten antiretroviral medicines. The annexes include the 12th WHO Model List of Essential Medicines in its usual presentation and, for the first time, in the five-level Anatomical Therapeutic Chemical (ATC) classification system.

Contents:

Title Page

Contents

1. Introduction

2. Open session

3. The new procedures for updating and disseminating the Model List

3.1 Background

3.2 Key features of the new procedures

3.3 Review of the new procedures

3.3.1 Applications for additions

3.3.2 Applications for deletions

3.3.3 Selection criteria

3.4 The WHO model formulary

3.5 The WHO Essential Medicines Library

4. Other outstanding technical issues

4.1 Change of name of the Expert Committee

4.2 Description of essential medicines

4.3 Role of treatment costs in relation to the Model List

4.4 Inclusion of additional items in the Model List

5. Format and presentation of the 12th Model List

5.1 Section headings

5.2 The core and complementary lists

5.3 The "square box" symbol

6. Changes made in revising the Model List

6.1 Applications for additions

6.1.1 Antiretroviral medicines

6.1.2 Artemether + lumefantrine (fixed-dose combination)

6.1.3 a /b -Arteether

6.1.4 Artemotil (b -arteether)

6.1.5 Amodiaquine

6.1.6 Insecticide-treated bednets

6.1.7 Miconazole nitrate buccal tablets

6.2 Applications for deletions

6.3 Other changes

6.3.1 Meglumine antimoniate

6.3.2 Antineoplastic and immunosuppressive medicines

6.3.3 Reserve list medicines

7. Future reviews of sections of the Model List

7.1 Update on the review of medicines for the treatment of hypertension

7.2 Review of the core and complementary lists

7.3 Review of the use of the "square box" symbol

7.4 Review of injectable medicines

7.5 Priorities for further systematic reviews

8. Recommendations

8.1 Procedures for updating and disseminating the Model List of Essential Medicines

8.2 Description of essential medicines

8.3 Presentation of the 12th Model List

8.4 Additions and changes to the Model List.

8.5 Deferred applications

8.6 Rejected applications

8.7 Priorities for future reviews of sections of the Model List

8.8 Change of name of the Expert Committee

8.9 Other recommendations

Acknowledgements

References

Annex 1 The 12th WHO Model List of Essential Medicines

Annex 2 Additional notes on the medicines recommended for inclusion in the 12th WHO Model List of Essential Medicines

Annex 3 The Anatomical Therapeutic Chemical (ATC) classification system

Alphabetical list of essential medicinces (with ATC classification codes).

Notes:

Bibliographic Level Mode of Issuance: Monograph

ISBN:

1-280-04131-5

9786610041312

92-4-068131-0

OCLC:

476034972